Setting

Europe Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248556 | Pages: 129

Europe organ transplant diagnostics market was valued at $ 706.4 million in 2021 and will grow by 8.6% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics. Highlighted with 41 tables and 62 figures, this 129-page report “Europe Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Test Kits & Consumables o Kits & Assays o Consumables • Software & Services Based on Transplant, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Solid Organ Transplant o Kidney o Liver o Heart o Lung o Pancreas o Kidney-Pancreas o Other Solid Organ Transplants • Stem Cell Transplant • Soft Tissue Transplant By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostics o Donor Testing o Recipient Testing • Translational Research By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Molecular Technologies o PCR o Sequencing o Other Molecular Technologies • Serology • Flow Cytometry • Other Technologies By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Transplant Centers • Reference Laboratories • Academic and Research Institutions • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Inc. ARUP Laboratories BAG Health Care GmbH Becton Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CareDx, Inc. Eurofins Scientific F. Hoffmann-La Roche Ltd. Illumina, Inc. Immucor, Inc. Laboratory Corporation of America Holdings Novacyt Group Omixon Ltd. OPKO Health QIAGEN N.V. Quest Diagnostics Incorporated Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	32
2.4 Emerging Opportunities and Market Trends	35
2.5 Porter’s Fiver Forces Analysis	39
3 Segmentation of Europe Market by Offering	43
3.1 Market Overview by Offering	43
3.2 Instruments	45
3.3 Test Kits & Consumables	47
3.3.1 Kits & Assays	48
3.3.2 Consumables	50
3.4 Software & Services	52
4 Segmentation of Europe Market by Transplant	54
4.1 Market Overview by Transplant	54
4.2 Solid Organ Transplant	56
4.2.1 Kidney	58
4.2.2 Liver	59
4.2.3 Heart	60
4.2.4 Lung	61
4.2.5 Pancreas	62
4.2.6 Kidney-Pancreas	63
4.2.7 Other Solid Organ Transplants	64
4.3 Stem Cell Transplant	65
4.4 Soft Tissue Transplant	66
5 Segmentation of Europe Market by Application	67
5.1 Market Overview by Application	67
5.2 Diagnostics	69
5.2.1 Donor Testing	70
5.2.2 Recipient Testing	71
5.3 Translational Research	72
6 Segmentation of Europe Market by Technology	73
6.1 Market Overview by Technology	73
6.2 Molecular Technologies	75
6.2.1 PCR	77
6.2.2 Sequencing	78
6.2.3 Other Molecular Technologies	79
6.3 Serology	80
6.4 Flow Cytometry	81
6.5 Other Technologies	82
7 Segmentation of Europe Market by End User	83
7.1 Market Overview by End User	83
7.2 Hospitals and Transplant Centers	85
7.3 Reference Laboratories	86
7.4 Academic and Research Institutions	87
7.5 Other End Users	88
8 European Market 2021-2031 by Country	89
8.1 Overview of European Market	89
8.2 Germany	92
8.3 U.K.	94
8.4 France	96
8.5 Spain	98
8.6 Italy	100
8.7 Netherlands	102
8.8 Rest of European Market	104
9 Competitive Landscape	106
9.1 Overview of Key Vendors	106
9.2 New Product Launch, Partnership, Investment, and M&A	109
9.3 Company Profiles	110
Abbott Laboratories Inc.	110
ARUP Laboratories	112
BAG Health Care GmbH	113
Becton Dickinson and Company	114
bioMérieux S.A.	115
Bio-Rad Laboratories, Inc.	116
CareDx, Inc.	117
Eurofins Scientific	118
F. Hoffmann-La Roche Ltd.	119
Illumina, Inc.	120
Immucor, Inc.	121
Laboratory Corporation of America Holdings	122
Novacyt Group	123
Omixon Ltd.	124
OPKO Health	125
QIAGEN N.V.	126
Quest Diagnostics Incorporated	127
Thermo Fisher Scientific Inc.	128
RELATED REPORTS	129
List of Tables:

Table 1.  Snapshot of Europe Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	31
Table 5.  Main Product Trends and Market Opportunities in Europe Organ Transplant Diagnostics Market	35
Table 6. Europe Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	43
Table 7. Main Platforms and Key Vendors	46
Table 8. Europe Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn	47
Table 9. Main Kits & Assays and Key Vendors	49
Table 10. Main Consumables and Key Vendors	51
Table 11. Main Services and Key Vendors	53
Table 12. Europe Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	54
Table 13. Europe Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn	57
Table 14. Europe Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn	67
Table 15. Europe Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn	69
Table 16. Europe Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	73
Table 17. Europe Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn	76
Table 18. Europe Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn	83
Table 19. Europe Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn	91
Table 20. Germany Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	93
Table 21. Germany Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	93
Table 22. Germany Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	93
Table 23. U.K. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	95
Table 24. U.K. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	95
Table 25. U.K. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	95
Table 26. France Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	97
Table 27. France Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	97
Table 28. France Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	97
Table 29. Spain Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	99
Table 30. Spain Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	99
Table 31. Spain Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	99
Table 32. Italy Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	101
Table 33. Italy Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	101
Table 34. Italy Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	101
Table 35. Netherlands Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	103
Table 36. Netherlands Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	103
Table 37. Netherlands Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	103
Table 38. Organ Transplant Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn	105
Table 39. Abbott Laboratories Inc.: Company Snapshot	110
Table 40. Abbott Laboratories Inc.: Business Segmentation	111
Table 41. Abbott Laboratories Inc.: Product Portfolio	111
List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. Europe Organ Transplant Diagnostics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	24
Figure 6. Primary Drivers and Impact Factors of Europe Organ Transplant Diagnostics Market	26
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	29
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	30
Figure 10. Primary Restraints and Impact Factors of Europe Organ Transplant Diagnostics Market	32
Figure 11. Investment Opportunity Analysis	36
Figure 12. Porter’s Fiver Forces Analysis of Europe Organ Transplant Diagnostics Market	39
Figure 13. Breakdown of Europe Organ Transplant Diagnostics Market by Offering, 2021-2031, % of Revenue	44
Figure 14. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	44
Figure 15. Europe Organ Transplant Diagnostics Market by Offering: Instruments, 2021-2031, $ mn	45
Figure 16. Europe Organ Transplant Diagnostics Market by Offering: Test Kits & Consumables, 2021-2031, $ mn	47
Figure 17. Europe Organ Transplant Diagnostics Market by Test Kits & Consumables: Kits & Assays, 2021-2031, $ mn	48
Figure 18. Europe Organ Transplant Diagnostics Market by Test Kits & Consumables: Consumables, 2021-2031, $ mn	50
Figure 19. Europe Organ Transplant Diagnostics Market by Offering: Software & Services, 2021-2031, $ mn	52
Figure 20. Breakdown of Europe Organ Transplant Diagnostics Market by Transplant, 2021-2031, % of Sales Revenue	55
Figure 21. Europe Addressable Market Cap in 2022-2031 by Transplant, Value ($ mn) and Share (%)	55
Figure 22. Europe Organ Transplant Diagnostics Market by Transplant: Solid Organ Transplant, 2021-2031, $ mn	56
Figure 23. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney, 2021-2031, $ mn	58
Figure 24. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Liver, 2021-2031, $ mn	59
Figure 25. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Heart, 2021-2031, $ mn	60
Figure 26. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Lung, 2021-2031, $ mn	61
Figure 27. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Pancreas, 2021-2031, $ mn	62
Figure 28. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney-Pancreas, 2021-2031, $ mn	63
Figure 29. Europe Organ Transplant Diagnostics Market by Solid Organ Transplant: Other Solid Organ Transplants, 2021-2031, $ mn	64
Figure 30. Europe Organ Transplant Diagnostics Market by Transplant: Stem Cell Transplant, 2021-2031, $ mn	65
Figure 31. Europe Organ Transplant Diagnostics Market by Transplant: Soft Tissue Transplant, 2021-2031, $ mn	66
Figure 32. Breakdown of Europe Organ Transplant Diagnostics Market by Application, 2021-2031, % of Sales Revenue	68
Figure 33. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	68
Figure 34. Europe Organ Transplant Diagnostics Market by Application: Diagnostics, 2021-2031, $ mn	69
Figure 35. Europe Organ Transplant Diagnostics Market by Diagnostics: Donor Testing, 2021-2031, $ mn	70
Figure 36. Europe Organ Transplant Diagnostics Market by Diagnostics: Recipient Testing, 2021-2031, $ mn	71
Figure 37. Europe Organ Transplant Diagnostics Market by Application: Translational Research, 2021-2031, $ mn	72
Figure 38. Breakdown of Europe Organ Transplant Diagnostics Market by Technology, 2021-2031, % of Revenue	74
Figure 39. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	74
Figure 40. Europe Organ Transplant Diagnostics Market by Technology: Molecular Technologies, 2021-2031, $ mn	75
Figure 41. Europe Organ Transplant Diagnostics Market by Molecular Technologies: PCR, 2021-2031, $ mn	77
Figure 42. Europe Organ Transplant Diagnostics Market by Molecular Technologies: Sequencing, 2021-2031, $ mn	78
Figure 43. Europe Organ Transplant Diagnostics Market by Molecular Technologies: Other Molecular Technologies, 2021-2031, $ mn	79
Figure 44. Europe Organ Transplant Diagnostics Market by Technology: Serology, 2021-2031, $ mn	80
Figure 45. Europe Organ Transplant Diagnostics Market by Technology: Flow Cytometry, 2021-2031, $ mn	81
Figure 46. Europe Organ Transplant Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn	82
Figure 47. Breakdown of Europe Organ Transplant Diagnostics Market by End User, 2021-2031, % of Revenue	84
Figure 48. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	84
Figure 49. Europe Organ Transplant Diagnostics Market by End User: Hospitals and Transplant Centers, 2021-2031, $ mn	85
Figure 50. Europe Organ Transplant Diagnostics Market by End User: Reference Laboratories, 2021-2031, $ mn	86
Figure 51. Europe Organ Transplant Diagnostics Market by End User: Academic and Research Institutions, 2021-2031, $ mn	87
Figure 52. Europe Organ Transplant Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	88
Figure 53. Breakdown of European Organ Transplant Diagnostics Market by Country, 2021 and 2031, % of Revenue	90
Figure 54. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	91
Figure 55.  Organ Transplant Diagnostics Market in Germany, 2021-2031, $ mn	92
Figure 56.  Organ Transplant Diagnostics Market in U.K., 2021-2031, $ mn	94
Figure 57.  Organ Transplant Diagnostics Market in France, 2021-2031, $ mn	96
Figure 58.  Organ Transplant Diagnostics Market in Spain, 2021-2031, $ mn	98
Figure 59.  Organ Transplant Diagnostics Market in Italy, 2021-2031, $ mn	100
Figure 60.  Organ Transplant Diagnostics Market in Netherlands, 2021-2031, $ mn	102
Figure 61.  Organ Transplant Diagnostics Market in Rest of Europe, 2021-2031, $ mn	104
Figure 62. Growth Stage of Europe Organ Transplant Diagnostics Industry over the Forecast Period	106
Selected Key Players: 
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)